Approval · Notice of Compliance 17892 · 2016
FIRMAGON: Notice of Compliance 17892
Issued March 22, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17892
- Date
- March 22, 2016
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph to incorporate the results of additional completed trials
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIRMAGON | Not yet assigned | — |
Medicinal ingredients
- DEGARELIX ACETATE 80 MG per VIAL
- DEGARELIX ACETATE 120 MG per VIAL